Cargando…
“New” Antigenic Targets and Methodological Approaches for Refining Laboratory Diagnosis of Antiphospholipid Syndrome
Antiphospholipid antibodies (aPLs) are a heterogeneous group of antibodies directed against phospholipids or protein/phospholipid complexes. Currently, aPLs are assessed using either “solid-phase” assays that identify anticardiolipin antibodies and anti-β2-glycoprotein I antibodies or “liquid-phase”...
Autores principales: | Misasi, Roberta, Capozzi, Antonella, Longo, Agostina, Recalchi, Serena, Lococo, Emanuela, Alessandri, Cristiano, Conti, Fabrizio, Valesini, Guido, Sorice, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383493/ https://www.ncbi.nlm.nih.gov/pubmed/25874238 http://dx.doi.org/10.1155/2015/858542 |
Ejemplares similares
-
The Mosaic of “Seronegative” Antiphospholipid Syndrome
por: Conti, Fabrizio, et al.
Publicado: (2014) -
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome
por: Manganelli, Valeria, et al.
Publicado: (2017) -
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome
por: Truglia, Simona, et al.
Publicado: (2022) -
Molecular Mechanisms of “Antiphospholipid Antibodies” and Their Paradoxical Role in the Pathogenesis of “Seronegative APS”
por: Misasi, Roberta, et al.
Publicado: (2020) -
Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome
por: Manganelli, Valeria, et al.
Publicado: (2019)